RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
RENEW | SUBSCRIBE
Home » Resources » News and Research
Subscribe or renew to PPM

All News and Research Articles

Should Chronic Pain be Redefined?
IASP offers a new description of "pain" to account for the individual's intersubjective experience.
Amgen/Novartis Move Successful Endpoint Results of Erenumab to First Migraine Preventive Approval in US
with Lawrence Robbins, MD, and representatives from Amgen/Novartis
Canadian Clinicians Release New Practice Guideline on Prescribing Benzodiazepines
For the treatment of insomnia, benzodiazepines should be carefully prescribed.
FDA Approves First Non-Opioid Treatment to Manage Withdrawal
A PPM Brief
Lilly, Teva Meet Endpoints for Cluster Headache & Migraine; Amgen/Novartis Gain FDA Approval of Aimovig
Amgen/Novartis have been awaiting an FDA decision on their collaborative erenumab (Aimovig), a calcitonin gene-related peptide (CGRP) monoclonal antibody for the prevention of migraine since they submitted a BLA for the novel treatment last July. Announced late in the day on May 17, 2018, FDA has granted approval to Amgen Inc.
Synthetic Opioid Addiction May be More Prevalent due to Brain Reactions
A PPM Brief
Four AAPM Board Members Appointed to New US HHS Task Force
The Task Force's inaugural public meeting will be held in late May 2018 from Washington, DC
Morphine Sulfate Oral Solution Approved
ANI Pharmaceuticals Announces Approval of Morphine Sulfate Oral Solution for acute and chronic pain.
Studies Continue to Target Opioids and Their Alternatives in Chronic Pain Management
Focus on opioid use disorder sparks more research into the long-term effects of opioid therapy, tapering, referrals, and opioid alternatives
Braeburn Pharma Announces OUD Resource
The company’s mission is to advance a portfolio of next-generation therapies on opioid addiction.
FDA, AAPM Open Talks on Evidence-Based Opioid Prescribing
FDA and US administrative tone regarding opioid use for chronic pain management and treatment takes a turn; talks opened for developing evidence-based opioid prescribing guidelines.
Could Hunger Alter Responses to Chronic Pain?
Hunger activates a neural pathway that inhibits the perception and response to pain.
Nerve Block for Regional Analgesia Supplements Pain Management Toolkits
Pacira's approved expanded indication of Exparel (bupivacaine liposome injectable suspension) for upper extremity surgeries provides an extended-duration, nonopioid anesthetic alternative.
NIH to Increase Opioid and Pain Research by $500 Million
NIH HEAL initiative will aim to reduce over-prescription of opioids, as well as misuse and addiction, and accelerate development of non-opioid therapies
CDC Opioid Overdose Death Rates Over-Reported by Half
Miscounting prescription and illicit opioids together resulted in the CDC overdose rate to be too high.
SHOW MAIN MENU
SHOW SUB MENU